As lung cancer remains the leading cause of cancer-related deaths [27, 28], understanding the underlying molecular mechanism of NSCLC is desired; EIF4G2 is known to participate in the regulation of cisplatin (CDDP) resistance [26]. This evidence concerns the gene EIF4G2 and lung cancer.